14.19Open16.25Pre Close1 Volume3 Open Interest95.00Strike Price1.42KTurnover189.90%IV0.53%PremiumDec 13, 2024Expiry Date13.61Intrinsic Value100Multiplier1DDays to Expiry0.58Extrinsic Value100Contract SizeAmericanOptions Type0.9441Delta0.0120Gamma7.84Leverage Ratio-0.6828Theta0.0018Rho7.40Eff Leverage0.0056Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet